Mark Stolper is Director of SURGALIGN HOLDINGS, INC.. Currently has a direct ownership of 28,867 shares of SRGA, which is worth approximately $288. The most recent transaction as insider was on Aug 15, 2022, when has been sold 22,857 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K
0% 3M change
0% 12M change
Total Value Held $288

MARK STOLPER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2022
BUY
Grant, award, or other acquisition
-
22,857 Added 44.19%
28,867 Common Stock
May 07 2021
BUY
Grant, award, or other acquisition
-
57,803 Added 25.83%
165,946 Common Stock
Feb 01 2021
BUY
Open market or private purchase
$25,000 $1.5 p/Share
16,667 Added 13.35%
108,143 Common Stock

Also insider at

RDNT
RadNet, Inc. Healthcare
CHRS
Coherus BioSciences, Inc. Healthcare
MS

Mark Stolper

Director
Deerfield, IL

Track Institutional and Insider Activities on SRGA

Follow SURGALIGN HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRGA shares.

Notify only if

Insider Trading

Get notified when an Surgalign Holdings, Inc. insider buys or sells SRGA shares.

Notify only if

News

Receive news related to SURGALIGN HOLDINGS, INC.

Track Activities on SRGA